MedPath

Clinical value of (improved) 3 Tesla and 7 Tesla MR Imaging on depiction of T1 laryngeal carcinoma

Completed
Conditions
cancer of the vocal cord
laryngeal carcinoma
10038666
10029107
Registration Number
NL-OMON42195
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patients with primary clinical Tis, T1a and T1b glottic carcinoma, scheduled for treatment with CO2 laser therapy or radiotherapy
- Capablility of written informed consent
- Written informed consent

Exclusion Criteria

- Patients with a history of previous glottic surgery
- Patients with recurrence of glottic disease
- Legal incapability
- Insufficient command of the Dutch language
- Patients with body implants, not compatible with MRI
- Patients with Claustrofobia
- Pregnant patients
- Creatinine clearance of <50mL/min/1.73m²
- Known allergy for Gadovist or Iodinated contrast

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath